Skip to content

The diagnostic value and clinical significance of enhanced MRI in meningeal metastasis of malignant tumor

The diagnostic value and clinical significance of enhanced MRI in meningeal metastasis of malignant tumor

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050054
Enrollment
Unknown
Registered
2021-08-16
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal membrane metastasis

Interventions

Gold Standard:Pathological results
Index test:Spinal&#32
and&#32
type United&#32
imaging&#32
1.5TMRI

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients who have been clinically confirmed (surgery pathology or puncture pathology) with a history of malignant tumors, have corresponding clinical symptoms and MRI enhancement confirmed meningeal metastasis; 2. Patients who have informed consent to undergo spinal MRI enhancement examination, can cooperate and have no claustrophobia; 3. Those who are not allergic to MRI contrast agent (gadopentetate meglumine (Gd-DTPA)); 4. The course of disease and treatment are not limited, age and gender are not limited.

Exclusion criteria

Exclusion criteria: 1. Patients who refuse to do MRI enhancement; 2. Patients with complicated pregnancy who cannot do MRI.

Design outcomes

Primary

MeasureTime frame
Types of spinal membrane metastasis;Scope of spinal membrane metastasis;

Countries

China

Contacts

Public ContactSun Xiqi

Shanghai Sixth People's Hospital

xqsun1234@163.com+86 18916086291

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026